Cleveland Diagnostics is preparing to roll out its newly approved prostate cancer test kit in early 2026, with plans to ...
First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...
The use of a rapid test to diagnose pertussis cases early in the clinical course can also decrease the duration and severity ...
India's diagnostic services market is expected to maintain double-digit growth (~12% CAGR) by FY30, driven by rising ...
The diagnosis time for endometriosis, one of the most common diseases among women, could be cut from years to weeks with a ...
The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...
Rahul Guha, MD & CEO of Thyrocare Technologies, said the group does not plan any further stake sale in Thyrocare, but will ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
MedPage Today on MSNOpinion
What I Think Is Really Going on With Trump's Imaging Tests
Now, if the President had any new symptoms related to the chest, abdomen, or pelvis, advanced imaging might be warranted.
These practical, case-focused sessions at Fetch Long Beach promise to deliver immediate, clinic-ready skills.
Leveraging the profound legacy of Lords Mark Industries, a powerhouse with 25 years of excellence in Security paper, solar & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback